ID

31863

Descrizione

Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA); ODM derived from: https://clinicaltrials.gov/show/NCT00791999

collegamento

https://clinicaltrials.gov/show/NCT00791999

Keywords

versioni (1)
  1. 05/10/18 05/10/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

5 ottobre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Rheumatoid Arthritis NCT00791999

Inglese

Eligibility Rheumatoid Arthritis NCT00791999

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects must have a diagnosis of adult-onset ra of at least 6 months but not longer than 15 years in duration as defined by the 1987 american college of rheumatology classification criteria.
Descrizione

Adult onset Rheumatoid Arthritis Duration

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1853562
UMLS CUI [1,2]
C0003873
UMLS CUI [1,3]
C0449238
subjects must have active ra disease as defined by:
Descrizione

Rheumatoid Arthritis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0003873
at least 9 tender joints and 9 swollen joints
Descrizione

Tender joint count | Swollen joint count

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0451530
UMLS CUI [2]
C0451521
esr of 30 mm/hour or crp of 1.5 mg/dl
Descrizione

Erythrocyte sedimentation rate measurement | C-reactive protein measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1176468
UMLS CUI [2]
C0201657
subjects must have received treatment with mtx for at least 6 months prior to the start of study drug administration. the dose of mtx must have remain fixed for at least 2 months prior to the study and the dose of mtx should be within 6 to 8 mg/week.
Descrizione

Methotrexate Dose Stable U/week

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0560588
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who have a diagnosis of any other inflammatory arthritis
Descrizione

Arthritis Other

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0003864
UMLS CUI [1,2]
C0205394
patients who have a secondary, non-inflammatory type of arthritis (eg, osteoarthritis, fibromyalgia)
Descrizione

Arthritis Secondary Noninflammatory | Osteoarthritis | Fibromyalgia

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0003864
UMLS CUI [1,2]
C0175668
UMLS CUI [1,3]
C0442743
UMLS CUI [2]
C0029408
UMLS CUI [3]
C0016053
patients who currently have, or who have a history of, a demyelinating or convulsive disease of the central nervous system (eg, multiple sclerosis, epilepsy)
Descrizione

Demyelinating disease of central nervous system | Convulsive disorder Central Nervous System | Multiple Sclerosis | Epilepsy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011302
UMLS CUI [2,1]
C0234972
UMLS CUI [2,2]
C3714787
UMLS CUI [3]
C0026769
UMLS CUI [4]
C0014544
patients who have nyha (new york heart association) class iii or iv congestive heart failure
Descrizione

Congestive heart failure New York Heart Association Classification

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C1275491
patients who currently have, or who have a history of, tuberculosis
Descrizione

Tuberculosis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0041296
patients who have a high risk of infection (with a current infectious disease, a chronic infectious disease, a history of serious infectious disease)
Descrizione

High risk of Communicable Disease | Communicable Disease | Chronic infectious disease | Communicable Disease Serious

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C0009450
UMLS CUI [2]
C0009450
UMLS CUI [3]
C0151317
UMLS CUI [4,1]
C0009450
UMLS CUI [4,2]
C0205404
patients who currently have, or who have a history of, malignancy
Descrizione

Malignant Neoplasms

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
female patients who are breastfeeding or pregnant, who are of childbearing potential
Descrizione

Breast Feeding | Pregnancy | Childbearing Potential

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
UMLS CUI [3]
C3831118
patients who previously received treatment with 2 or more anti-tnfα drugs or who previously failed to respond to treatment with 1 or more aint-tnfα drugs.
Descrizione

Anti-TNF alpha drug Quantity | Anti-TNF alpha drug Quantity Unresponsive to Treatment

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1562242
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1562242
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0205269
Ritorna all'inizio della pagina

Similar models

Eligibility Rheumatoid Arthritis NCT00791999

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Adult onset Rheumatoid Arthritis Duration
Item
subjects must have a diagnosis of adult-onset ra of at least 6 months but not longer than 15 years in duration as defined by the 1987 american college of rheumatology classification criteria.
boolean
C1853562 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Rheumatoid Arthritis
Item
subjects must have active ra disease as defined by:
boolean
C0003873 (UMLS CUI [1])
Tender joint count | Swollen joint count
Item
at least 9 tender joints and 9 swollen joints
boolean
C0451530 (UMLS CUI [1])
C0451521 (UMLS CUI [2])
Erythrocyte sedimentation rate measurement | C-reactive protein measurement
Item
esr of 30 mm/hour or crp of 1.5 mg/dl
boolean
C1176468 (UMLS CUI [1])
C0201657 (UMLS CUI [2])
Methotrexate Dose Stable U/week
Item
subjects must have received treatment with mtx for at least 6 months prior to the start of study drug administration. the dose of mtx must have remain fixed for at least 2 months prior to the study and the dose of mtx should be within 6 to 8 mg/week.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
Arthritis Other
Item
patients who have a diagnosis of any other inflammatory arthritis
boolean
C0003864 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Arthritis Secondary Noninflammatory | Osteoarthritis | Fibromyalgia
Item
patients who have a secondary, non-inflammatory type of arthritis (eg, osteoarthritis, fibromyalgia)
boolean
C0003864 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
C0442743 (UMLS CUI [1,3])
C0029408 (UMLS CUI [2])
C0016053 (UMLS CUI [3])
Demyelinating disease of central nervous system | Convulsive disorder Central Nervous System | Multiple Sclerosis | Epilepsy
Item
patients who currently have, or who have a history of, a demyelinating or convulsive disease of the central nervous system (eg, multiple sclerosis, epilepsy)
boolean
C0011302 (UMLS CUI [1])
C0234972 (UMLS CUI [2,1])
C3714787 (UMLS CUI [2,2])
C0026769 (UMLS CUI [3])
C0014544 (UMLS CUI [4])
Congestive heart failure New York Heart Association Classification
Item
patients who have nyha (new york heart association) class iii or iv congestive heart failure
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Tuberculosis
Item
patients who currently have, or who have a history of, tuberculosis
boolean
C0041296 (UMLS CUI [1])
High risk of Communicable Disease | Communicable Disease | Chronic infectious disease | Communicable Disease Serious
Item
patients who have a high risk of infection (with a current infectious disease, a chronic infectious disease, a history of serious infectious disease)
boolean
C0332167 (UMLS CUI [1,1])
C0009450 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2])
C0151317 (UMLS CUI [3])
C0009450 (UMLS CUI [4,1])
C0205404 (UMLS CUI [4,2])
Malignant Neoplasms
Item
patients who currently have, or who have a history of, malignancy
boolean
C0006826 (UMLS CUI [1])
Breast Feeding | Pregnancy | Childbearing Potential
Item
female patients who are breastfeeding or pregnant, who are of childbearing potential
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C3831118 (UMLS CUI [3])
Anti-TNF alpha drug Quantity | Anti-TNF alpha drug Quantity Unresponsive to Treatment
Item
patients who previously received treatment with 2 or more anti-tnfα drugs or who previously failed to respond to treatment with 1 or more aint-tnfα drugs.
boolean
C1562242 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1562242 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0205269 (UMLS CUI [2,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial